Leonard Mazur
2018
In 2018, Leonard Mazur earned a total compensation of $398.3K as Executive Chairman at Citius Pharmaceuticals, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $103,750 |
|---|---|
| Option Awards | $44,572 |
| Salary | $250,000 |
| Total | $398,322 |
Mazur received $250K in salary, accounting for 63% of the total pay in 2018.
Mazur also received $103.8K in non-equity incentive plan and $44.6K in option awards.
Rankings
In 2018, Leonard Mazur's compensation ranked 12,558th out of 14,244 executives tracked by ExecPay. In other words, Mazur earned more than 11.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,558 out of 14,244 | 12th |
Division Manufacturing | 5,086 out of 5,765 | 12th |
Major group Chemicals And Allied Products | 1,930 out of 2,128 | 9th |
Industry group Drugs | 1,654 out of 1,817 | 9th |
Industry Pharmaceutical Preparations | 1,267 out of 1,391 | 9th |
Source: SEC filing on December 20, 2018.
Mazur's colleagues
We found two more compensation records of executives who worked with Leonard Mazur at Citius Pharmaceuticals in 2018.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018